Product Information

VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2007 per EA under NDC 65862055190. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Mar 21, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB

Valsartan and Hydrochlorothiazide
$0.2007per EA

Strength

25; 320 mg/1; mg/1

NDC

65862055190

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA202519

FDA Approved

3/21/2013

TE Code

AB

On Market Since

3/21/2013

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 54.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2007 per EA
All-time high$0.6097 (Nov 11, 2020)
All-time low$0.1905 (Nov 20, 2024)
52-week high$0.2220
52-week low$0.2007
Median price$0.3103
Average price$0.3235
Largest weekly change+33.7% (Oct 21, 2020)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-4.6%

1M

-4.6%

3M

-8.9%

6M

-8.6%

1Y

-6.6%

3Y

-27.1%

5Y

-54.2%

All

-54.1%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.2007 per EA (NDC 65862055190), effective Aug 19, 2026.

How has the price of VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB changed over time?

Over the history we have for it, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB has declined 54.1%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?

Since Nov 28, 2013, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB has ranged from a low of $0.1905 (Nov 20, 2024) to a high of $0.6097 (Nov 11, 2020), with a median of $0.3103 per EA.

Are there cheaper alternatives to VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?

VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB (NDC 65862055190) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.